{"id":5081,"date":"2015-08-11T09:00:00","date_gmt":"2015-08-11T09:00:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/"},"modified":"2024-09-23T11:22:40","modified_gmt":"2024-09-23T11:22:40","slug":"psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/","title":{"rendered":"Psoriasis medicijn kan auto-immuunreactie T1D remmen"},"content":{"rendered":"<a href=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2015\/08\/icoon-regeneratie1-1.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-3241 alignright\" src=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/icoon-regeneratie1-300x300-1.jpg\" alt=\"icoon regeneratie[1]\" width=\"300\" height=\"300\" \/><\/a>Door Breakthrough T1D gefinancierde onderzoekers in de Verenigde Staten hebben ontdekt dat het medicijn Alefacept, wat gebruikt wordt bij de huidziekte psoriasis ervoor kan zorgen dat de insulineproducerende cellen bij Type 1 Diabetes (T1D) niet langer vernietigd worden.\n\nIn een tweejarig onderzoek bij mensen die kort gediagnosticeerd waren met T1D werd vastgesteld dat mensen die Alefacept kregen, 15 maanden na de laatste keer dat ze het gebruikten, nog steeds minder insuline hoefden te gebruiken en hogere C-peptide levels hadden dan de mensen die een placebo hadden gekregen. Hieruit valt op te maken dat mensen die Alefacept in een vroeg stadium na de diagnose van T1D krijgen, langer meer eigen insuline maken.\n\nToen de hoeveelheid immuuncellen tussen de twee groepen werd vergelijken bleek dat mensen die Alefacept hadden genomen hogere levels van immuunsysteemregulerende cellen in hun lichaam hadden en minder b\u00e8tacel vernietigende cellen. Het medicijn kan insulineproducerende cellen dus gezond houden door het immuunsysteem aan te passen en het vermogen om een immuunaanval te veroorzaken te verminderen.\n\nDr. Gerald Nepom, directeur van het \u2018Immunne Tolerance Network\u2019, is licht optmistisch over de volgende fase van het onderzoek: \u201chet is altijd afwachten of iets wat op korte termijn werkt, ook op lange termijn resultaat op levert. Er moet gedetailleerde analyse worden uitgevoerd op het bloed van beide groepen zodat we de beste manier kunnen ontwikkelen om deze immuuntherapie geschikt te maken voor T1D en mogelijk andere auto-immuunziekten.\u201d\n\n<a href=\"http:\/\/www.jci.org\/articles\/view\/81722?key=396fe7fed2acc7286e9a\">Het hele artikel vind je hier<\/a>","protected":false,"raw":""},"excerpt":{"rendered":"<p>Door Breakthrough T1D gefinancierde onderzoekers in de Verenigde Staten hebben ontdekt dat het medicijn Alefacept, wat gebruikt wordt bij de huidziekte psoriasis ervoor kan zorgen dat de insulineproducerende cellen bij Type 1 Diabetes (T1D) niet langer vernietigd worden. In een tweejarig onderzoek bij mensen die kort gediagnosticeerd waren met T1D werd vastgesteld dat mensen die [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184,195],"tags":[],"class_list":["post-5081","post","type-post","status-publish","format-standard","hentry","category-archief","category-voorkomen"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Psoriasis medicijn kan auto-immuunreactie T1D remmen - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Psoriasis medicijn kan auto-immuunreactie T1D remmen - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Door Breakthrough T1D gefinancierde onderzoekers in de Verenigde Staten hebben ontdekt dat het medicijn Alefacept, wat gebruikt wordt bij de huidziekte psoriasis ervoor kan zorgen dat de insulineproducerende cellen bij Type 1 Diabetes (T1D) niet langer vernietigd worden. In een tweejarig onderzoek bij mensen die kort gediagnosticeerd waren met T1D werd vastgesteld dat mensen die [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2015-08-11T09:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/icoon-regeneratie1-300x300-1.jpg\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Psoriasis medicijn kan auto-immuunreactie T1D remmen\",\"datePublished\":\"2015-08-11T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/\"},\"wordCount\":251,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/icoon-regeneratie1-300x300-1.jpg\",\"articleSection\":[\"Archief\",\"Voorkomen\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/\",\"name\":\"Psoriasis medicijn kan auto-immuunreactie T1D remmen - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/icoon-regeneratie1-300x300-1.jpg\",\"datePublished\":\"2015-08-11T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Psoriasis medicijn kan auto-immuunreactie T1D remmen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Psoriasis medicijn kan auto-immuunreactie T1D remmen - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/","og_locale":"nl_NL","og_type":"article","og_title":"Psoriasis medicijn kan auto-immuunreactie T1D remmen - Breakthrough T1D","og_description":"Door Breakthrough T1D gefinancierde onderzoekers in de Verenigde Staten hebben ontdekt dat het medicijn Alefacept, wat gebruikt wordt bij de huidziekte psoriasis ervoor kan zorgen dat de insulineproducerende cellen bij Type 1 Diabetes (T1D) niet langer vernietigd worden. In een tweejarig onderzoek bij mensen die kort gediagnosticeerd waren met T1D werd vastgesteld dat mensen die [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/","og_site_name":"Breakthrough T1D","article_published_time":"2015-08-11T09:00:00+00:00","article_modified_time":"2024-09-23T11:22:40+00:00","og_image":[{"url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/icoon-regeneratie1-300x300-1.jpg","type":"","width":"","height":""}],"author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Psoriasis medicijn kan auto-immuunreactie T1D remmen","datePublished":"2015-08-11T09:00:00+00:00","dateModified":"2024-09-23T11:22:40+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/"},"wordCount":251,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/icoon-regeneratie1-300x300-1.jpg","articleSection":["Archief","Voorkomen"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/","name":"Psoriasis medicijn kan auto-immuunreactie T1D remmen - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/#primaryimage"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/icoon-regeneratie1-300x300-1.jpg","datePublished":"2015-08-11T09:00:00+00:00","dateModified":"2024-09-23T11:22:40+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/psoriasis-medicijn-kan-auto-immuunreactie-t1d-remmen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Psoriasis medicijn kan auto-immuunreactie T1D remmen"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5081","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5081"}],"version-history":[{"count":3,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5081\/revisions"}],"predecessor-version":[{"id":7954,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5081\/revisions\/7954"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5081"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5081"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5081"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}